Isomorphic Labs Raises $2.1B for AI Drug Discovery
Isomorphic Labs raises $2.1B for AI drug discovery — one of the largest capital raises in AI-for-science. The Alphabet-backed company, founded by DeepMind CEO Demis Hassabis, expands its pharmaceutical AI platform.
